As mentioned above, the antitumor mechanisms of these drugs involve the regulation of the expression of p53, NF-κB, STAT, and VEGF, leading to the suppression of tumor cell proliferation, metastasis, invasion, and angiogenesis. The gene discussed is NFKB1; the disease is neoplasm.